CannRx delivers advanced, clinically validated, unique cannabis formulations paired with pharmaceutical grade delivery systems for an entirely new cannabis inhalation experience. We develop cutting-edge technologies designed to treat a diverse range of medical conditions qualifying for medical cannabis treatment.
WHAT WE DO
CannRx has created the most advanced extraction technology – VCT patented vapor capture technology. The VCT creates liquid soluble cannabinoid profiles that can be used in downstream pharmaceuticals including Oral Dissolving Tablets, Sublinguals, Topicals, Patches, and Inhalation Solutions.
CannRx is rethinking inhaled cannabis in order to bring to market, for the first time, a line of non-combusted, dose-able cannabis formulations with controlled levels of critical cannabinoids, terpenes, and whole plant trace elements clinically tested to treat the symptoms of specific medical indications.
With our patented extract technology, our liquid cannabis formulations significantly increase bioavailability by penetrating deeper into the lungs and delivering the formulation more efficiently. Our products also utilize standard pharmaceutical grade processing and clinical trials.
WHY WE DO IT
Our patients are our parents, our grandparents, and our children. At CannRx, we believe that the future of cannabis is inhaled – not combusted. We chose the sleep market for our first product, iCAN sleep, because reports have shown that 47% of patients entering dispensaries are seeking a sleep aid.
FOR MORE INFORMATION VISIT CANNRX